- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Hong Kong Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
8
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
8 companies
Ascentage Pharma Group International
Market Cap: HK$24.9b
A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
6855
HK$67.55
7D
8.4%
1Y
58.9%
RemeGen
Market Cap: HK$52.2b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$85.45
7D
2.9%
1Y
398.5%
Akeso
Market Cap: HK$109.4b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$118.80
7D
5.9%
1Y
72.8%
Ocumension Therapeutics
Market Cap: HK$6.9b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$8.50
7D
1.8%
1Y
66.7%
InnoCare Pharma
Market Cap: HK$29.1b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$15.17
7D
8.4%
1Y
121.5%
CanSino Biologics
Market Cap: HK$15.5b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$46.00
7D
4.8%
1Y
58.9%
Nanjing Leads Biolabs
Market Cap: HK$11.7b
A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.
9887
HK$59.00
7D
0.9%
1Y
n/a
JBM (Healthcare)
Market Cap: HK$2.3b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.85
7D
-0.3%
1Y
120.9%